Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.76 CHF | -1.02% | -0.77% | +56.77% |
Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Transcript : Newron Pharmaceuticals S.p.A., 2023 Earnings Call, Mar 19, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+56.77% | 161M | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B |
- Stock
- Equities
- Stock Newron Pharmaceuticals S.p.A. - Swiss Exchange
- News Newron Pharmaceuticals S.p.A.
- Newron Pharmaceuticals S.p.A. announced that it has received €40 million in funding from European Investment Bank, Investment Arm